Clinical Trials Directory

Trials / Conditions / Type 2 Papillary Renal Cell Carcinoma

Type 2 Papillary Renal Cell Carcinoma

6 registered clinical trials studyying Type 2 Papillary Renal Cell Carcinoma.

StatusTrialSponsorPhase
CompletedTesting Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed
NCT02761057
National Cancer Institute (NCI)Phase 2
CompletedBevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer
NCT01727089
National Cancer Institute (NCI)Phase 2
CompletedTivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Ki
NCT01688973
National Cancer Institute (NCI)Phase 2
CompletedMycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Mali
NCT00078858
Fred Hutchinson Cancer CenterPhase 1 / Phase 2
CompletedTotal-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Tr
NCT00027820
Fred Hutchinson Cancer CenterPhase 1 / Phase 2
CompletedFludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients Wi
NCT00005799
Fred Hutchinson Cancer CenterN/A